Learn About Suicide Risk Assessment and Response in Primary Care

OSUWexnerbloglogo2014 Learn About Suicide Risk Assessment and Response in Primary Care on webcast. Nearly every primary care physician has had a patient die from suicide. But there is something that all of us can do about it. We can better identify our patients at risk for suicide and we can more effectively talk with our patients about suicide. On this CME webcast, we’re going to be discussing suicide risk assessment and response in primary care. We’d like to welcome our guests. Clinical psychologist and Professor in the Department of Psychiatry, Dr. Craig Bryan. And also clinical psychologist and Assistant Professor in the Department of Psychiatry, Dr. Justin Baker.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: describe how items from the Suicide Cognitions Scale-Revised can improve the accuracy of suicide risk screening and assessment; and identify the components of crisis response planning for suicide prevention.

You’ll also learn about the following:

  • ‘Red flags’ for emergency care
  • When to refer outpatients
  • What to look for when referring a patient to a mental health professional
  • National Suicide Prevention Lifeline

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About Suicide Risk Assessment on Webcast

OSUWexnerbloglogo2014 Learn About Suicide Risk Assessment on Webcast. On this CME webcast, we are going to be discussing the assessment of suicide to give you the tools you need to recognize suicide risks so that you can direct patients to psychiatric care that can save their lives. Joining us in the studio is Professor and Vice Chairman of Department of Psychiatry from the Ohio State University, Dr. Eileen Ryan.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the major risk factors and warning signs for suicide; and assess patients for suicidal risk.

You’ll also learn about the following:

  • Epidemiology of suicide
  • Suicide assessment tools
  • Medical hold for suicidal patients
  • Resources for physicians in outpatient settings
  • Overview of the treatment approach to suicidal patients
  • Time course for SSRI effectiveness

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches on Clostridium difficile

OSUWexnerbloglogo2014 On-line Education Teaches on Clostridium difficile. On this CME webcast, we are going to discuss Clostridioides difficile: how to diagnosis it, how to treat it, and most importantly, how to prevent it in your patients and in your hospital. Let me welcome today’s guests. Lisa Hines is an infection preventionist in the Department of Clinical Epidemiology at the OSU Wexner Medical Center. And Dr. Christina Liscynesky is an Assistant Professor of Internal Medicine from the Division of Infectious Disease and the Associate Medical Director of Clinical Epidemiology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the difference between C diff assays; UNDERSTAND the different medications used to treat C. diff.; DESCRIBE the pathophysiology of Clostridioides difficile infection (CDI); and IDENTIFY at least two infection prevention measures to decrease the spread of Clostridioides difficile infections (CDI) in the healthcare setting.

You’ll also learn about the following:

  • Risk factors for C. diff
  • Diagnostic challenges
  • Mattresses and C. diff
  • Ultraviolet light emitters
  • Probiotic preparations
  • Other clinical presentations of C. diff
  • Antibiotic stewardship
  • When to call a surgeon

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Macular Degeneration

OSUWexnerbloglogo2014 CME Webcast Discusses Macular Degeneration. On this CME webcast, we’re going to update you on the current approaches to the diagnosis and treatment of macular degeneration. Let me welcome today’s guests. Dr. Matthew Ohr is an Associate Professor of Ophthalmology and the Interim Chairman of the Department of Ophthalmology. And Dr. Fatoumata Yanoga is a retinal specialist and Assistant Professor of Ophthalmology.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW Characteristics of Age-Related Macular Degeneration; DISCUSS Modifiable Risk Factors that can Lead to Prevention of Disease; DEFINE neovascular macular degeneration; and DISCUSS the diagnosis and management of wet macular degeneration.

You’ll also learn about the following:

  • Risk factors for macular degeneration
  • Prognosis of macular degeneration
  • Screening for macular degeneration in the primary care office
  • Assessing risks when starting a patient on anticoagulation

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast

OSUWexnerbloglogo2014 Learn the Latest on Hepatocellular Carcinoma Viewing CME Webcast. Here in the United States, the incidence of hepatocellular carcinoma is rising. The way that we approach cancer of the liver has changed over the past 20 years and today on MedNet, we are going to bring you up to date on the epidemiology, screening, diagnosis, and treatment of hepatocellular carcinoma. Joining us today is hepatologist and Assistant Professor of Internal Medicine, Dr. Lanla F. Conteh.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the epidemiology of hepatocellular carcinoma in the United States; and RECOGNIZE which patients should be screened for hepatocellular carcinoma.

You’ll also learn about the following:

  • The rising incidence of hepatocellular carcinoma
  • New directions in treatment of hepatocellular carcinoma
  • Imaging test of choice in suspected hepatocellular carcinoma
  • How to biopsy suspected hepatocellular carcinoma
  • Viral hepatitis risk factors for hepatocellular carcinoma
  • Fibrolamellar hepatocellular carcinoma

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.